XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,751 | +28.1% | 3,887 | +44.4% | 0.00% | – |
Q2 2023 | $103,591 | +324.5% | 2,691 | +294.6% | 0.00% | – |
Q1 2023 | $24,402 | -9.6% | 682 | +0.9% | 0.00% | – |
Q4 2022 | $27,000 | +22.7% | 676 | +14.4% | 0.00% | – |
Q3 2022 | $22,000 | +175.0% | 591 | +124.7% | 0.00% | – |
Q2 2022 | $8,000 | +166.7% | 263 | +163.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -50.0% | 100 | -73.3% | 0.00% | – |
Q3 2021 | $6,000 | -14.3% | 375 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | -46.2% | 375 | -50.0% | 0.00% | – |
Q1 2021 | $13,000 | +8.3% | 750 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | +50.0% | 750 | 0.0% | 0.00% | – |
Q3 2020 | $8,000 | -11.1% | 750 | 0.0% | 0.00% | – |
Q2 2020 | $9,000 | 0.0% | 750 | 0.0% | 0.00% | – |
Q1 2020 | $9,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |